Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy
Clinical trial NCT05696717 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05696717
- Sponsor
- Theravance Biopharma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-27
- Primary completion
- 2026-01-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.